Hospitalisations
2
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Implementation Of A Nurseled Model Of Care
Research Leaders
12 sponsors active, led by Vaud state public health department
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 2 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models
Nurse-led Care Models in Swiss Nursing Homes: Improving Interprofessional Care for Better Resident Outcomes (INTERCARE)
Research Network
Common Treatments
- Implementation Of A Nurseled Model Of Care1
- The Conventional Clopidogrel Treatment1
- Cyp2c19 Genotype Guided Antiplatelet Treatment Alternative To Clopidogrel1
- Cyp2c19 Genotypeguided Clopidogrel Treatment1
Active Sponsors
- Vaud state public health department1
- University Department of Geriatric Medicine FELIX PLATTER1
- Insel Gruppe AG, University Hospital Bern1
- University of Applied Sciences and Arts of Southern Switzerland1
- University of Basel1
Top Investigators
Tbilisi State Medical University
Vistamedi Ltd., Tbilisi Georgia
Vistamedi Ltd. Tbilisi, Georgia
Institut für Pflegewissenschaft Fakultät für Medizin, Universität Basel Bernoullistrasse 28, Raum 107 CH-4056 Basel
Related Conditions
- Coronary Thrombosis1
- Death1
- Coronary Artery Disease1
- Death From Cardiovascular Disease1
- Adverse Cardiac Events1